The DOI matches its Crossref record; 162 of the 162 references it cites were found in a registry or an index.
MDR- and CYP3A4-mediated drug–herbal interactions
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
Gottesman, M. M., & Pastan, I. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002125 · Cited by 3,568
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
Juliano, R. L., & Ling, V. (1976) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(76)90160-7 · Cited by 3,296
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G. (1992) · Science · doi:10.1126/science.1360704 · Cited by 3,037
Why Patients Use Alternative Medicine: Results of a National Study
Astin, J. A. (1998) · JAMA · doi:10.1001/jama.279.19.1548 · Cited by 2,865
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
Zhou, S., Schuetz, J. D., Bunting, K. D., Colapietro, A.-M., Sampath, J., Morris, J. J., Lagutina, I., Grosveld, G. C., Osawa, M., Nakauchi, H., et al. (2001) · Nature Medicine · doi:10.1038/nm0901-1028 · Cited by 2,280
BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER
Ambudkar, S. V., Dey, S., Hrycyna, C. A., Ramachandra, M., Pastan, I., & Gottesman, M. M. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.361 · Cited by 2,059
Chen, C.-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., & Roninson, I. B. (1986) · Cell · doi:10.1016/0092-8674(86)90595-7 · Cited by 1,898
A family of drug transporters: the multidrug resistance-associated proteins
Borst, P., Evers, R., Kool, M., & Wijnholds, J. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.16.1295 · Cited by 1,751
Hyde, S. C., Emsley, P., Hartshorn, M. J., Mimmack, M. M., Gileadi, U., Pearce, S. R., Gallagher, M. P., Gill, D. R., Hubbard, R. E., & Higgins, C. F. (1990) · Nature · doi:10.1038/346362a0 · Cited by 1,145
Schinkel, A. H., Wagenaar, E., van Deemter, L., Mol, C. A., & Borst, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118214 · Cited by 1,107
Fugh-Berman, A. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06457-0 · Cited by 1,099
P-glycoprotein: from genomics to mechanism
Ambudkar, S. V., Kimchi-Sarfaty, C., Sauna, Z. E., & Gottesman, M. M. (2003) · Oncogene · doi:10.1038/sj.onc.1206948 · Cited by 1,074
Ueda, K., Cardarelli, C., Gottesman, M. M., & Pastan, I. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.9.3004 · Cited by 1,063
Role of P-Glycoprotein in Pharmacokinetics: Clinical Implications
Lin, J. H., & Yamazaki, M. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342010-00003 · Cited by 998
St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor
Moore, L. B., Goodwin, B., Jones, S. A., Wisely, G. B., Serabjit-Singh, C. J., Willson, T. M., Collins, J. L., & Kliewer, S. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130155097 · Cited by 947
(2006) · Pharmacodynamic Basis of Herbal Medicine, Second Edition · doi:10.1201/9781420006452.ch4 · Cited by 905
Gain of function mutations in p53
Dittmer, D., Pati, S., Zambetti, G., Chu, S., Teresky, A. K., Moore, M., Finlay, C., & Levine, A. J. (1993) · Nature Genetics · doi:10.1038/ng0593-42 · Cited by 894
Indinavir concentrations and St John's wort
Piscitelli, S. C., Burstein, A. H., Chaitt, D., Alfaro, R. M., & Falloon, J. (2000) · The Lancet · doi:10.1016/s0140-6736(99)05712-8 · Cited by 874
Wacher, V. J., Wu, C., & Benet, L. Z. (1995) · Molecular Carcinogenesis · doi:10.1002/mc.2940130302 · Cited by 857
van Helvoort, A., Smith, A. J., Sprong, H., Fritzsche, I., Schinkel, A. H., Borst, P., & van Meer, G. (1996) · Cell · doi:10.1016/s0092-8674(00)81370-7 · Cited by 855
The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux
Synold, T. W., Dussault, I., & Forman, B. M. (2001) · Nature Medicine · doi:10.1038/87912 · Cited by 840
IN VITRO AND IN VIVO DRUG INTERACTIONS INVOLVING HUMAN CYP3A
Thummel, K. E., & Wilkinson, G. R. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.389 · Cited by 831
Congenital Jaundice in Rats with a Mutation in a Multidrug Resistance-Associated Protein Gene
Paulusma, C. C., Bosma, P. J., Zaman, G. J. R., Bakker, C. T. M., Otter, M., Scheffer, G. L., Scheper, R. J., Borst, P., & Elferink, R. P. J. O. (1996) · Science · doi:10.1126/science.271.5252.1126 · Cited by 822
Human P450 metabolism of warfarin
Kaminsky, L. S., & Zhang, Z.-Y. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00140-4 · Cited by 798
Long-Term Trends in the Use of Complementary and Alternative Medical Therapies in the United States
Kessler, R. C., Davis, R. B., Foster, D. F., Van Rompay, M. I., Walters, E. E., Wilkey, S. A., Kaptchuk, T. J., & Eisenberg, D. M. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-4-200108210-00011 · Cited by 746
Grapefruit juice–drug interactions
Bailey, D. G., Malcolm, J., Arnold, O., & David Spence, J. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00764.x · Cited by 740
Modulation of Activity of the Promoter of the Human MDR 1 Gene by Ras and p53
Chin, K.-V., Ueda, K., Pastan, I., & Gottesman, M. M. (1992) · Science · doi:10.1126/science.1346476 · Cited by 726
Guengerich, F. P., Martin, M. V., Beaune, P. H., Kremers, P., Wolff, T., & Waxman, D. J. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89213-x · Cited by 724
Interactions Between Herbal Medicines and Prescribed Drugs: A Systematic Review
Izzo, A. A., & Ernst, E. (2001) · Drugs · doi:10.2165/00003495-200161150-00002 · Cited by 714
Litman, T., Druley, T. E., Stein, W. D., & Bates, S. E. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000912 · Cited by 688
Acute heart transplant rejection due to Saint John's wort
Ruschitzka, F., Meier, P. J., Turina, M., Lüscher, T. F., & Noll, G. (2000) · The Lancet · doi:10.1016/s0140-6736(99)05467-7 · Cited by 644
Role of Breast Cancer Resistance Protein in the Bioavailability and Fetal Penetration of Topotecan
Jonker, J. W. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.20.1651 · Cited by 638
Harmless Herbs? A Review of the Recent Literature
Ernst, E. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00397-5 · Cited by 634
OATP and P-Glycoprotein Transporters Mediate the Cellular Uptake and Excretion of Fexofenadine
Cvetkovic, M., Leake, B., Fromm, M. F., Wilkinson, G. R., & Kim, R. B. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15235-x · Cited by 597
JOHNE, A. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1053/cp.1999.v66.a101944 · Cited by 586
St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4
Dürr, D. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.112240 · Cited by 584
Paulusma, C. C., Kool, M., Bosma, P. J., Scheffer, G. L., ter Borg, F., Scheper, R. J., Tytgat, G. N., Borst, P., Baas, F., & Elferink, R. O. (1997) · Hepatology · doi:10.1002/hep.510250635 · Cited by 552
Kronbach, T., Fischer, V., & Meyer, U. A. (1988) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1988.87 · Cited by 533
Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes.
Kolars, J. C., Schmiedlin-Ren, P., Schuetz, J. D., Fang, C., & Watkins, P. B. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116064 · Cited by 528
Ito, K., Iwatsubo, T., Kanamitsu, S., Ueda, K., Suzuki, H., & Sugiyama, Y. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01372-3 · Cited by 512
Ritonavir: Clinical Pharmacokinetics and Interactions with Other Anti-HIV Agents
Hsu, A., Granneman, G. R., & Bertz, R. J. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199835040-00002 · Cited by 483
Watkins, P. B., Wrighton, S. A., Schuetz, E. G., Molowa, D. T., & Guzelian, P. S. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113156 · Cited by 480
Induction of Drug Metabolism: The Role of Nuclear Receptors
Handschin, C., & Meyer, U. A. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.2 · Cited by 470
The P-Glycoprotein Efflux Pump: How Does it Transport Drugs?
Sharom, F. J. (1997) · Journal of Membrane Biology · doi:10.1007/s002329900305 · Cited by 458
Effects of St. John's wort on irinotecan metabolism.
Mathijssen, R. H. J. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.16.1247 · Cited by 457
Human liver carbamazepine metabolism
Kerr, B. M., Thummel, K. E., Wurden, C. J., Klein, S. M., Kroetz, D. L., Gonzalez, F. J., & Levy, R. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90071-x · Cited by 433
The effect of garlic supplements on the pharmacokinetics of saquinavir
Piscitelli, S. C., Burstein, A. H., Welden, N., Gallicano, K. D., & Falloon, J. (2002) · Clinical Infectious Diseases · doi:10.1086/324351 · Cited by 431
Wacher, V. J., Silverman, J. A., Zhang, Y., & Benet, L. Z. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980082d · Cited by 423
Role of transport proteins in drug absorption, distribution and excretion
Ayrton, A., & Morgan, P. (2001) · Xenobiotica · doi:10.1080/00498250110060969 · Cited by 421
Obach, R. S. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39043-3 · Cited by 397
Chin, K. V., Tanaka, S., Darlington, G., Pastan, I., & Gottesman, M. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40219-6 · Cited by 393
The barrier function of CYP3A4 and P-glycoprotein in the small bowel
Watkins, P. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00041-0 · Cited by 391
Effect of grapefruit juice on digoxin pharmacokinetics in humans
Becquemont, L., Verstuyft, C., Kerb, R., Brinkmann, U., Lebot, M., Jaillon, P., & Funck‐Brentano, C. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(01)17221-8 · Cited by 387
Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters
Leslie, E. (2001) · Toxicology · doi:10.1016/s0300-483x(01)00454-1 · Cited by 376
Sotaniemi, E. A., Haapakoski, E., & Rautio, A. (1995) · Diabetes Care · doi:10.2337/diacare.18.10.1373 · Cited by 375
Regulation of the Human CYP2B6 Gene by the Nuclear Pregnane X Receptor
Goodwin, B., Moore, L. B., Stoltz, C. M., McKee, D. D., & Kliewer, S. A. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12603-x · Cited by 374
Herb–drug interactions: Review and assessment of report reliability
Fugh‐Berman, A., & Ernst, E. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01469.x · Cited by 364
Chaudhary, P. M., & Roninson, I. B. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.8.632 · Cited by 360
Vuksan, V., Sievenpiper, J. L., Koo, V. Y. Y., Francis, T., Beljan-Zdravkovic, U., Xu, Z., & Vidgen, E. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.7.1009 · Cited by 354
Kumar, G. N., Rodrigues, A. D., Buko, A. M., & Denissen, J. F. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12840-1 · Cited by 353
Spontaneous Hyphema Associated with Ingestion of Ginkgo biloba Extract
Rosenblatt, M., & Mindel, J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361518 · Cited by 341
Probable interaction between warfarin and ginseng
Janetzky, K., & Morreale, A. P. (1997) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/54.6.692 · Cited by 326
St John's Wort: Effect on CYP3A4 activity
Roby, C. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.106793 · Cited by 316
Active secretion and enterocytic drug metabolism barriers to drug absorption
Wacher, V. J., Salphati, L., & Benet, L. Z. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00127-s · Cited by 308
Second thoughts about safety of St John's wort
Ernst, E. (1999) · The Lancet · doi:10.1016/s0140-6736(99)00418-3 · Cited by 305
Silymarin protects against paracetamol‐induced lipid peroxidation and liver damage
Muriel, P., Garciapiña, T., Perez‐Alvarez, V., & Mourelle, M. (1992) · Journal of Applied Toxicology · doi:10.1002/jat.2550120613 · Cited by 301
St John's Wort increases expression of P‐glycoprotein: Implications for drug interactions
Hennessy, M., Kelleher, D., Spiers, J. P., Barry, M., Kavanagh, P., Back, D., Mulcahy, F., & Feely, J. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01516.x · Cited by 280
Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity
Henderson, G. L., Harkey, M. R., Gershwin, M. E., Hackman, R. M., Stern, J. S., & Stresser, D. M. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00407-5 · Cited by 274
Scambia, G., Ranelletti, F. O., Panici, P. B., De Vincenzo, R., Bonanno, G., Ferrandina, G., Piantelli, M., Bussa, S., Rumi, C., Cianfriglia, M., et al. (1994) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685655 · Cited by 271
(1997) · PubMed · Cited by 271
Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects
Dresser, G. K., Schwarz, U. I., Wilkinson, G. R., & Kim, R. B. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2003.10 · Cited by 261
Pharmacokinetic Interactions of Drugs with St John’s Wort
Zhou, S., Chan, E., Pan, S.-Q., Huang, M., & Lee, E. J. D. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104042632 · Cited by 253
Drug Interactions with Grapefruit Juice: Extent, Probable Mechanism and Clinical Relevance
Fuhr, U. (1998) · Drug Safety · doi:10.2165/00002018-199818040-00002 · Cited by 252
Bordia, A., Verma, S. K., & Srivastava, K. C. (1998) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(98)90034-5 · Cited by 249
Wacher, V. J., Salphati, L., & Benet, L. Z. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00126-5 · Cited by 245
Pharmacokinetic interactions between herbal remedies and medicinal drugs
Ioannides, C. (2002) · Xenobiotica · doi:10.1080/00498250210124147 · Cited by 237
Rose, K. D., Croissant, P. D., Parliament, C. F., & Levin, M. B. (1990) · Neurosurgery · doi:10.1097/00006123-199005000-00026 · Cited by 236
St John's wort, a herbal antidepressant, activates the steroid X receptor
Wentworth, J., Agostini, M., Love, J., Schwabe, J., & Chatterjee, V. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.166r011 · Cited by 236
Effect of grapefruit juice on digoxin pharmacokinetics in humans.
Becquemont, L., Verstuyft, C., Kerb, R., Brinkmann, U., Lebot, M., Jaillon, P., & Funck‐Brentano, C. (2001) · PubMed · Cited by 234
Fitzsimmons, M. E., & Collins, J. M. (1997) · PubMed · Cited by 221
Rose, K. D., Croissant, P. D., Parliament, C. F., & Levin, M. B. (1990) · Neurosurgery · doi:10.1227/00006123-199005000-00026 · Cited by 217
Effect of St John's wort on the pharmacokinetics of fexofenadine
Wang, Z., Hamman, M. A., Huang, S., Lesko, L. J., & Hall, S. D. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.124080 · Cited by 213
Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humans.
Santos, A., Zanetta, S., Cresteil, T., Deroussent, A., Pein, F. J. L., Raymond, É., Vernillet, L., Risse, M., Boige, V., Gouyette, A., et al. (2000) · PubMed · Cited by 213
Oral Bioavailability of Hyperforin from Hypericum Extracts in Rats and Human Volunteers
Biber, A., Fischer, H., Römer, A., & Chatterjee, S. (1998) · Pharmacopsychiatry · doi:10.1055/s-2007-979344 · Cited by 212
St. John's Wort and Antidepressant Drug Interactions in the Elderly
Lantz, M. S., Buchalter, E., & Giambanco, V. (1999) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879901200103 · Cited by 208
Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity
Zou, L., Harkey, M. R., & Henderson, G. L. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01913-6 · Cited by 204
Potential Metabolic Interaction between St. John's Wort and Theophylline
(1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18252 · Cited by 201
The Contribution of P‐glycoprotein to Pharmacokinetic Drug‐Drug Interactions
Yu, D. K. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/00912709922012006 · Cited by 199
Effect of quercetin on hoechst 33342 transport by purified and reconstituted p-glycoprotein
Shapiro, A. B., & Ling, V. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00826-x · Cited by 194
HMG‐CoA reductase inhibitors and P‐glycoprotein modulation
Bogman, K., Peyer, A., Török, M., Küsters, E., & Drewe, J. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703920 · Cited by 194
Safety of St John's wort (Hypericum perforatum)
Yue, Q.-Y., Bergquist, C., & Gerdén, B. (2000) · The Lancet · doi:10.1016/s0140-6736(05)73227-x · Cited by 191
Immunomodulatory effects of two extracts of Panax ginseng C.A. Meyer.
Scaglione, F., Ferrara, F., Dugnani, S., Falchi, M., Santoro, G., & FRASCHINI, F. (1990) · PubMed · Cited by 189
Herbal medicines: current trends in anesthesiology practice—a hospital survey
Kaye, A. D., Clarke, R. C., Sabar, R., Vig, S., Dhawan, K. P., Hofbauer, R., & Kaye, A. M. (2000) · Journal of Clinical Anesthesia · doi:10.1016/s0952-8180(00)00195-1 · Cited by 189
Bauer, S., Störmer, E., Johne, A., Krüger, H., Budde, K., Neumayer, H., Roots, I., & Mai, I. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01759.x · Cited by 188
Saquinavir, an HIV Protease Inhibitor, Is Transported by P-Glycoprotein
Kim, A. E., Dintaman, J. M., Waddell, D. S., & Silverman, J. A. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37742-0 · Cited by 177
Venkatakrishnan, K., Greenblatt, D. J., Moltke, L. L., Schmider, J., Harmatz, J. S., & Shader, R. I. (1998) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1998.tb04399.x · Cited by 175
Safety of St John's wort (Hypericum perforatum)
De Smet, P. A., & Touw, D. J. (2000) · The Lancet · doi:10.1016/s0140-6736(05)73225-6 · Cited by 174
Function, evolution and structure of multidrug resistance protein (MRP)
Deeley, R. G., & Cole, S. P. C. (1997) · Seminars in Cancer Biology · doi:10.1006/scbi.1997.0070 · Cited by 173
Johne, A., Schmider, J., Brockmöller, J., Stadelmann, A. M., Störmer, E., Bauer, S., Scholler, G., Langheinrich, M., & Roots, I. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200202000-00008 · Cited by 172
Parkinson, A. (1996) · Toxicologic Pathology · doi:10.1177/019262339602400107 · Cited by 169
P-glycoproteins in pathology: The multidrug resistance gene family in humans
Weinstein, R. S., Kuszak, J. R., Kluskens, L. F., & Coon, J. S. (1990) · Human Pathology · doi:10.1016/0046-8177(90)90073-e · Cited by 168
Saint John's wort: An in vitro analysis of P‐glycoprotein induction due to extended exposure
Perloff, M. D., Von Moltke, L. L., Störmer, E., Shader, R. I., & Greenblatt, D. J. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704399 · Cited by 166
Metabolism of theophylline by cDNA‐expressed human cytochromes P‐450.
Ha, H., Chen, J., Freiburghaus, A., & Follath, F. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb04455.x · Cited by 166
Drug interaction of St John's wort with ciclosporin
Breidenbach, T., Hoffmann, M., Becker, T., Schlitt, H., & Klempnauer, J. (2000) · The Lancet · doi:10.1016/s0140-6736(05)73359-6 · Cited by 164
Thottassery, J. V., Zambetti, G. P., Arimori, K., Schuetz, E. G., & Schuetz, J. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.11037 · Cited by 163
P‐glycoprotein‐mediated intestinal and biliary digoxin transport in humans
Drescher, S., Glaeser, H., Mürdter, T., Hitzl, M., Eichelbaum, M., & Fromm, M. F. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2003.27 · Cited by 158
Scaglione, F., Cattaneo, G., Alessandria, M., & Cogo, R. (1996) · PubMed · Cited by 156
Regulation of mdr RNA levels in response to cytotoxic drugs in rodent cells.
Chin, K., Chauhan, S. S., Pastan, I. H., & Gottesman, M. M. (1990) · PubMed · Cited by 151
Chiba, M., Hensleigh, M., Nishime, J. A., Balani, S. K., & Lin, J. H. (1996) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07348-9 · Cited by 146
Drug Interactions of HIV Protease Inhibitors
Malaty, L. I., & Kuper, J. J. (1999) · Drug Safety · doi:10.2165/00002018-199920020-00005 · Cited by 146
Gallicano, K., Foster, B., & Choudhri, S. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01736.x · Cited by 146
Wilkinson, G. R. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00040-9 · Cited by 145
Karliova, M., Treichel, U., Malagó, M., Frilling, A., Gerken, G., & Broelsch, C. E. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80321-9 · Cited by 143
Washington, C. B., Durán, G. E., Man, M., Sikic, B. I., & Blaschke, T. F. (1998) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199811010-00001 · Cited by 143
Markowitz, J. S., DeVane, C. L., Boulton, D. W., Carson, S. W., Nahas, Z. H., & Risch, S. C. (2000) · Life Sciences · doi:10.1016/s0024-3205(99)00659-1 · Cited by 143
Patel, J., Buddha, B., Dey, S., Pal, D., & Mitra, A. K. (2004) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000101827.94820.22 · Cited by 139
Self-citationEffect of Milk Thistle on the Pharmacokinetics of Indinavir in Healthy Volunteers
Piscitelli, S. C., Formentini, E., Burstein, A. H., Alfaro, R. M., Jagannatha, S., & Falloon, J. (2002) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.8.551.33205 · Cited by 138
Influence of Dietary Components on the Gastrointestinal Metabolism and Transport of Drugs
Evans, A. M. (2000) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200002000-00028 · Cited by 138
Zhang, S., Yang, X., & Morris, M. E. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000033015.84146.4c · Cited by 138
Oral absorption of the HIV protease inhibitors: a current update
Williams, G. C., & Sinko, P. J. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00027-7 · Cited by 136
Clinical Guidelines for the Treatment of Depressive Disorders VII. Comorbidity
Enns, M. W., Swenson, J. R., McIntyre, R. S., Swinson, R. P., Kennedy, S. H., & The CANMAT Depression Work Group (2001) · The Canadian Journal of Psychiatry · doi:10.1177/070674372001460101007 · Cited by 136
Breidenbach, T., Kliem, V., Burg, M., Radermacher, J., Hoffmann, M. W., & Klempnauer, J. (2000) · Transplantation · doi:10.1097/00007890-200005270-00052 · Cited by 135
Characterization of human liver cytochromes P-450 involved in theophylline metabolism.
Sarkar, M. A., Hunt, C. M., Guzelian, P. S., & Karnes, H. T. (1992) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08515-0 · Cited by 135
Moody, D. E., Alburges, M. E., Parker, R., Collins, J. M., & Strong, J. M. (1997) · PubMed · Cited by 131
The Role of Half-Transporters in Multidrug Resistance
Bates, S. E., Robey, R. W., Miyake, K., Rao, K. V., Ross, D. D., & Litman, T. (2001) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1012879205914 · Cited by 130
Harenberg, J., Giese, C., & Zimmermann, R. (1988) · Atherosclerosis · doi:10.1016/0021-9150(88)90244-4 · Cited by 129
Lecureur, V., Sun, D., Hargrove, P., Schuetz, E. G., Kim, R. B., Lan, L.-B., & Schuetz, J. D. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26438-5 · Cited by 128
Garlic as a Possible Risk for Postoperative Bleeding
Burnham, B. E. (1995) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-199501000-00060 · Cited by 126
Zastawny, R. L., Salvino, R., Chen, J., Benchimol, S., & Ling (1993) · PubMed · Cited by 118
Luo, F., Paranjpe, P. V., Guo, A., Rubin, E. H., & Sinko, P. J. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.7.763 · Cited by 116
Metabolism of Amprenavir in Liver Microsomes: Role of CYP3A4 Inhibition for Drug Interactions
Decker, C. J., Laitinen, L. M., Bridson, G. W., Raybuck, S. A., Tung, R. D., & Chaturvedi, P. R. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980029p · Cited by 114
HERBAL SUPPLEMENTS: A POTENTIAL FOR DRUG INTERACTIONS IN TRANSPLANT RECIPIENTS
Barone, G. W., Gurley, B. J., Ketel, B. L., & Abul‐Ezz, S. R. (2001) · Transplantation · doi:10.1097/00007890-200101270-00012 · Cited by 111
SSRIs and St.John's Wort: possible toxicity?
Gordon, J. B. (1998) · PubMed · Cited by 103
Effects of Grapefruit Juice and Orange Juice on the Intestinal Efflux of P-Glycoprotein Substrates
Tian, R., Koyabu, N., Takanaga, H., Matsuo, H., Ohtani, H., & Sawada, Y. (2002) · Pharmaceutical Research · doi:10.1023/a:1016100715125 · Cited by 103
Venkatakrishnan, K., Moltke, L. L., & Greenblatt, D. J. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/00912709922008173 · Cited by 102
Activation of human multidrug resistance-1 gene promoter in response to heat shock stress
Miyazaki, M., Kohno, K., Uchiumi, T., Tanimura, H., Matsuo, K.-I., Nasu, M., & Kuwano, M. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91248-o · Cited by 95
Intracellular Trafficking and Regulation of Canalicular ATP-Binding Cassette Transporters
Kipp, H., & Arias, I. M. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9388 · Cited by 94
Barbenel, D., Yusufi, B., O'Shea, D. B., & Bench, C. J. (2000) · Journal of Psychopharmacology · doi:10.1177/026988110001400113 · Cited by 88
Effects of a dried garlic preparation on fibrinolysis and platelet aggregation in healthy subjects.
Legnani, C., Frascaro, M., Guazzaloca, G., Ludovici, S., Cesarano, G., & COCCHERI, S. (1993) · PubMed · Cited by 87
Modulation of P-glycoprotein phosphorylation and drug transport by sodium butyrate
Bates, S. E., Currier, S. J., Alvarez, M. G., & Fojo, A. T. (1992) · Biochemistry · doi:10.1021/bi00143a002 · Cited by 86
Review of Abnormal Laboratory Test Results and Toxic Effects Due to Use of Herbal Medicines
Dasgupta, A. (2003) · American Journal of Clinical Pathology · doi:10.1309/p024-k7vr-ddpj-ctvn · Cited by 86
Inhibitory effects of CYP3A4 substrates and their metabolites on P-glycoprotein-mediated transport
Katoh, M., Nakajima, M., Yamazaki, H., et al. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00215-3 · Cited by 84
Olesen, O. V., & Línnet, K. (2008) · Pharmacology · doi:10.1159/000139533 · Cited by 83
Transport, metabolism and elimination mechanisms of anti-HIV agents
Li, X., & Chan, W. K. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00021-6 · Cited by 80
Effects of flavonols on P-glycoprotein activity in cultured rat hepatocytes
Chieli, E., Romiti, N., Cervelli, F., & Tongiani, R. (1995) · Life Sciences · doi:10.1016/0024-3205(95)02152-9 · Cited by 75
Consumer Use of St. John's Wort: A Survey on Effectiveness, Safety, and Tolerability
Beckman, S. E., Sommi, R. W., & Switzer, J. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.6.568.35152 · Cited by 71
Possible serotonin syndrome after combination of buspirone and St John's Wort
Dannawi, M. (2002) · Journal of Psychopharmacology · doi:10.1177/026988110201600420 · Cited by 69
Patel, J., & Mitra, A. K. (2001) · Pharmacogenomics · doi:10.1517/14622416.2.4.401 · Cited by 66
Self-citationSpinella, M., & Eaton, L. A. (2002) · Brain Injury · doi:10.1080/02699050110103319 · Cited by 64
Relative Contribution of CYP3A to Amitriptyline Clearance in Humans: In Vitro and In Vivo Studies
Venkatakrishnan, K., Schmider, J., Harmatz, J. S., Ehrenberg, B. L., Moltke, L. L., Graf, J. A., Mertzanis, P., Corbett, K. E., Rodriguez, M. C., Shader, R. I., et al. (2001) · The Journal of Clinical Pharmacology · doi:10.1177/00912700122012634 · Cited by 63
St. John's Wort Extract Induces CYP3A and CYP2E1 in the Swiss Webster Mouse
Bray, B. J. (2002) · Toxicological Sciences · doi:10.1093/toxsci/66.1.27 · Cited by 62
Lacarelle, B., Rahmani, R., de Sousa, G., Durand, A., Placidi, M., & Cano, J. P. (1991) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1991.tb00746.x · Cited by 61
Hypericum perforatum (St John's wort) in depression: pest or blessing?
Rey, J. M., & Walter, G. (1998) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1998.tb123424.x · Cited by 59
Drug interaction between St John's Wort and quazepam
Kawaguchi, A., Ohmori, M., Tsuruoka, S., Nishiki, K., Harada, K., Miyamori, I., Yano, R., Nakamura, T., Masada, M., & Fujimura, A. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02171.x · Cited by 50
EFFECTS OF PANAX GINSENG ON BLOOD ALCOHOL CLEARANCE IN MAN
Lee, F. C., Ko, J. H., Park, J. K., & Lee, J. S. (1987) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1987.tb01510.x · Cited by 50
Transcription of the multidrug resistance gene MDR1: a therapeutic target.
Scotto, K. W., & Johnson, R. A. (2001) · PubMed · Cited by 50
Öğretmen, B., & Safa, A. R. (1999) · Biochemistry · doi:10.1021/bi991943f · Cited by 49
Potential Role of P-Glycoprotein in Affecting Hepatic Metabolism of Drugs
Chiou, W. L., Chung, S. M., & Wu, T. C. (2000) · Pharmaceutical Research · doi:10.1023/a:1007570517183 · Cited by 44
Agrosí, M., Mischiatti, S., Harrasser, P. C., & Savio, D. (2000) · Phytomedicine · doi:10.1016/s0944-7113(00)80029-x · Cited by 39
The effect of silibinin on experimental cyclosporine nephrotoxicity
Zima, T., KAMENÍKOVÁ, L., Kalousová, M., Buchar, E., Crkovska, J., & Tesař, V. (1998) · Renal Failure · doi:10.3109/08860229809045136 · Cited by 28
Combates, N. J., Kwon, P., Rzepka, R. W., & Cohen, D. (1997) · PubMed · Cited by 21
Cited by
RETRACTED: Quercetin: A flavonol with multifaceted therapeutic applications?
D'Andrea, G. (2015) · Fitoterapia · doi:10.1016/j.fitote.2015.09.018 · Cited by 721
RetractedThe flavonoid quercetin in disease prevention and therapy: Facts and fancies
Russo, M., Spagnuolo, C., Tedesco, I., Bilotto, S., & Russo, G. L. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.08.010 · Cited by 698
The Caco-2 cell monolayer: usefulness and limitations
Sun, H., Chow, E. C., Liu, S., Du, Y., & Pang, K. S. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.4.395 · Cited by 527
Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence
Lin, S., Chang, C., Hsu, C., Tsai, M., Cheng, H., Leong, M. K., Sung, P., Chen, J., & Weng, C. (2020) · British Journal of Pharmacology · doi:10.1111/bph.14816 · Cited by 425
Karlgren, M., Vildhede, A., Norinder, U., Wisniewski, J. R., Kimoto, E., Lai, Y., Haglund, U., & Artursson, P. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300212s · Cited by 369
Metadata
- Authors
- Pal, D., & Mitra, A. K.
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 2006-03
- Volume
- 78
- Issue
- 18
- Pages
- 2131-2145
- ISSN
- 0024-3205 (ISSN-L)
- OpenAlex
- W2078917293
- Cited by
- 254
- References
- 162
- FWCI
- 9.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.